PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

This month, Daniel Ghinn examines a 'ground-breaking' multichannel campaign from Pfizer, which puts engagement and trust-building ahead of pushing products ... and yet in popular culture the ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

That's especially the case when you invest in stocks that pay you to own them. I'm referring to dividend stocks, of course.

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...

Pfizer PFE-2.36%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN 1.12%increase; green up pointing triangle for 2.50 billion ...